PDE4A and lupus nephritis: In recent studies, Keravis et al [30] demonstrated that phosphodiesterase type 4 (PDE4) inhibitors, which are known to increase cAMP level by preventing degradation, ameliorate the progression of lupus nephritis in mouse models.